Literature DB >> 20466614

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion.

Ferran Guedea1, Alfredo Ramos, Ismael Herruzo, José Antonio Sánchez Calzado, Jorge Contreras, Jesús Romero, Jordi Craven-Bartle, Patricia Willisch, José Luis López Torrecilla, Xavier Maldonado, Gemma Sancho, Almudena Zapatero, Montserrat Ferrer, Yolanda Pardo, Pablo Fernández, Alfonso Mariño, Asunción Hervás, Víctor Macís, Ana Boladeras, Ferran Ferrer, Brian J Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466614     DOI: 10.1007/s12094-010-0511-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  20 in total

1.  Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Authors:  Montserrat Ferrer; José Francisco Suárez; Ferran Guedea; Pablo Fernández; Víctor Macías; Alfonso Mariño; Asunción Hervas; Ismael Herruzo; María José Ortiz; Humberto Villavicencio; Jordi Craven-Bratle; Olatz Garin; Ferran Aguiló
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-05       Impact factor: 7.038

2.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

Review 3.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies.

Authors:  Vincenzo Ficarra; Giacomo Novara; Walter Artibani; Andrea Cestari; Antonio Galfano; Markus Graefen; Giorgio Guazzoni; Bertrand Guillonneau; Mani Menon; Francesco Montorsi; Vipul Patel; Jens Rassweiler; Hendrik Van Poppel
Journal:  Eur Urol       Date:  2009-01-25       Impact factor: 20.096

Review 4.  EAU guidelines on prostate cancer.

Authors:  Axel Heidenreich; Gunnar Aus; Michel Bolla; Steven Joniau; Vsevolod B Matveev; Hans Peter Schmid; Filliberto Zattoni
Journal:  Eur Urol       Date:  2007-09-19       Impact factor: 20.096

5.  Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.

Authors:  Almudena Zapatero; Francisco Valcárcel; Felipe A Calvo; Rosa Algás; Amelia Béjar; Javier Maldonado; Salvador Villá
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

6.  The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.

Authors:  Naeem Bhojani; Umberto Capitanio; Nazareno Suardi; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Markus Graefen; Philippe Arjane; Alain Duclos; Jean-Baptiste Lattouf; Fred Saad; Luc Valiquette; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

7.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Authors:  Michael J Zelefsky; Zvi Fuks; Margie Hunt; Yoshiya Yamada; Christine Marion; C Clifton Ling; Howard Amols; E S Venkatraman; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

8.  Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.

Authors:  Ronald C Chen; Jack A Clark; James A Talcott
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

Review 9.  Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.

Authors:  Jenny Donovan; Nicola Mills; Monica Smith; Lucy Brindle; Ann Jacoby; Tim Peters; Stephen Frankel; David Neal; Freddie Hamdy
Journal:  BMJ       Date:  2002-10-05

Review 10.  Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Authors:  Timothy J Wilt; Roderick MacDonald; Indulis Rutks; Tatyana A Shamliyan; Brent C Taylor; Robert L Kane
Journal:  Ann Intern Med       Date:  2008-02-04       Impact factor: 25.391

View more
  1 in total

1.  Biochemical control of prostate cancer with iodine-125 brachytherapy alone: experience from a single institution.

Authors:  Larissa Pereira da Ponte Amadei; João Luis Fernandes Silva; Samir Abdallah Hanna; Cecília Maria Kalil Haddad; Adriano João Nesrallah; Heloisa Andrade Carvalho
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.